4//SEC Filing
Mohan Pankaj 4
Accession 0001209191-19-004233
CIK 0001649989other
Filed
Jan 16, 7:00 PM ET
Accepted
Jan 17, 4:45 PM ET
Size
7.1 KB
Accession
0001209191-19-004233
Insider Transaction Report
Form 4
Mohan Pankaj
DirectorPresident & CEO10% Owner
Transactions
- Purchase
Common Stock
2019-01-15$0.68/sh+8,000$5,440→ 7,064,553 total
Holdings
- 492,753(indirect: By Spouse)
Common Stock
- 39,405(indirect: By Children)
Common Stock
- 86,956(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6649 - $0.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.
Documents
Issuer
Outlook Therapeutics, Inc.
CIK 0001649989
Entity typeother
Related Parties
1- filerCIK 0001664386
Filing Metadata
- Form type
- 4
- Filed
- Jan 16, 7:00 PM ET
- Accepted
- Jan 17, 4:45 PM ET
- Size
- 7.1 KB